These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7187414)

  • 1. [Evaluation of the effect on the hypophysis-adrenal system of diflorasone diacetate in comparison to betamethasone 17-valerate in psoriasis patients].
    Albanese A; Califano L; Puglisi A; Silva A
    G Ital Dermatol Venereol; 1982; 117(5):LV-LIX. PubMed ID: 7187414
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical halcinonide and betamethasone valerate effects on plasma cortisol: acute and subacute usage studies.
    Gomez EC; Kaminester L; Frost P
    Arch Dermatol; 1977 Sep; 113(9):1196-202. PubMed ID: 332089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of the vasoconstrictor assay and clinical activity in psoriasis.
    Woodford R
    Arch Dermatol; 1986 Dec; 122(12):1355. PubMed ID: 3789765
    [No Abstract]   [Full Text] [Related]  

  • 4. [Assessment of value and risks of external treatment with clobetasol-17-propionate (Dermovate)].
    van der Harst LC; Smeenk G; Burger PM; van der Rhee HJ; Polano MK
    Ned Tijdschr Geneeskd; 1978 Feb; 122(7):219-23. PubMed ID: 345134
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of eczema. Once daily use of diflorasone diacetate in comparison to thrice daily use of betamethasone-17-valerate].
    Harder F; Rufli T
    Schweiz Rundsch Med Prax; 1983 Sep; 72(39):1240-2. PubMed ID: 6356122
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of betamethasone valerate inhalation on the hypothalamic-pituitary-adrenal axis or normal adults.
    Friedman M; Frears J; Crowley MF
    Postgrad Med J; 1974 Sep; 50 suppl 4():11-14. PubMed ID: 4467151
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative efficacy of once a day diflorasone diacetate and twice a day betamethasone valerate ointment applications in eczematous dermatitis.
    Johansson EA; Stiger TR
    Curr Med Res Opin; 1984; 9(4):259-64. PubMed ID: 6510015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short- and long-term safety assessment of a two-compound ointment containing calcipotriene/betamethasone dipropionate (Taclonex/Daivobet/Dovobet ointment): hypothalamic-pituitary-adrenal axis function in patients with psoriasis vulgaris.
    Fleming C; Ganslandt C; Leese GP
    J Drugs Dermatol; 2010 Aug; 9(8):969-74. PubMed ID: 20684147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind comparison of quarter strength clobetasol propionate in Unguentum Merck with betamethasone valerate in psoriasis.
    Stankler L
    Br J Clin Pract; 1983; 37(11-12):389-91. PubMed ID: 6367795
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of betamethasone dipropionate (0.05%) and betamethasone valerate (0.1%) ointments in psoriasis and other dermatoses--a multicentric double-blind clinical study.
    Sharma SD
    Indian J Dermatol; 1986; 31(2-3):34-7. PubMed ID: 3327820
    [No Abstract]   [Full Text] [Related]  

  • 11. [Double-blind evaluation of the effectiveness and tolerance of tipredane cream and betamethasone valerate cream in patients with psoriasis].
    Damasio M; Tacchini GA
    G Ital Dermatol Venereol; 1988 Sep; 123(9):IL-LI. PubMed ID: 3243575
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison between 2 steroid dosage forms in psoriasis and eczema].
    Björnberg A; Hellgren L
    Z Hautkr; 1975; Suppl 2():13-5. PubMed ID: 779298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of psoriasis with 0.1% domoprednate (a D-homocorticosteroid) and 0.1% betamethasone valerate ointment. A double-blind, randomized trial.
    Christiansen JV; Foged E; Holm P; Jørgensen AS; Reymann F
    Dermatologica; 1985; 170(4):195-8. PubMed ID: 3888709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of psoriasis: comparative study using allantoin coal tar extract combined with hydrocortisone and betamethasone valerate.
    Almeyda J; Wood H
    Br J Clin Pract; 1979 Apr; 33(4):106-8. PubMed ID: 475951
    [No Abstract]   [Full Text] [Related]  

  • 15. Etretinate (Tigason) and betamethasone valerate (Celeston valerate) in the treatment of psoriasis. A double-blind, randomized, multicenter trial.
    Christiansen JV; Holm P; Møller R; Reymann F; Schmidt H
    Dermatologica; 1982 Sep; 165(3):204-7. PubMed ID: 6751889
    [No Abstract]   [Full Text] [Related]  

  • 16. An open clinical trial comparing (paired comparisons) desoximetasone with betamethasone 17-valerate.
    Adam BA
    Med J Malaysia; 1978 Jun; 32(4):302-3. PubMed ID: 732627
    [No Abstract]   [Full Text] [Related]  

  • 17. Adrenal suppression with high-potency corticosteroid ointment formulations in normal subjects.
    Novak E; Francom SF; Schlagel CA
    Clin Ther; 1983; 6(1):59-71. PubMed ID: 6370438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of betamethasone valerate on the normal human facial skin flora.
    Daltrey DC; Cunliffe WJ
    Acta Derm Venereol; 1983; 63(2):160-2. PubMed ID: 6189335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of tar and betamethasone valerate in chronic plaque psoriasis: a study in Thailand.
    Thawornchaisit P; Harncharoen K
    J Med Assoc Thai; 2007 Oct; 90(10):1997-2002. PubMed ID: 18041415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of systemic adverse effects after prolonged local therapy with betamethasone-17-valerate ointment].
    Halsos AM
    Tidsskr Nor Laegeforen; 1978 Feb; 98(4):199-200. PubMed ID: 625746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.